Fulgent Genetics Stock Investor Sentiment

FLGT Stock  USD 17.48  0.03  0.17%   
Slightly above 67% of Fulgent Genetics' investor base is looking to short. The analysis of overall sentiment of trading Fulgent Genetics stock suggests that many investors are alarmed at this time. Fulgent Genetics' investing sentiment can be driven by a variety of factors including economic data, Fulgent Genetics' earnings reports, geopolitical events, and overall market trends.
  

Fulgent Genetics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Fulgent Genetics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at thelincolnianonline.com         
Fulgent Genetics, Inc. Shares Bought by Exchange Traded Concepts LLC
news
over a year ago at gurufocus.com         
Whats Driving Twist Bioscience Corps Surprising 89 percent Stock Rally?
Gurufocus Stories at Macroaxis
over a year ago at thelincolnianonline.com         
Fulgent Genetics, Inc. COO Jian Xie Sells 22,000 Shares
news
over a year ago at simplywall.st         
This Insider Has Just Sold Shares In Fulgent Genetics
Simply Wall St News at Macroaxis
over a year ago at thelincolnianonline.com         
Fulgent Genetics, Inc. Short Interest Down 33.4 percent in November
news
over a year ago at gurufocus.com         
Whats Driving Twist Bioscience Corps Surprising 60 percent Stock Rally?
Gurufocus Stories at Macroaxis
over a year ago at simplywall.st         
Is Fulgent Genetics Using Debt Sensibly?
Simply Wall St News at Macroaxis
over a year ago at www.macroaxis.com         
Sale by Jian Xie of 10000 shares of Fulgent Genetics
Macroaxis News
over a year ago at thelincolnianonline.com         
Fulgent Genetics Now Covered by Analysts at UBS Group
news
over a year ago at streetinsider.com         
UBS Starts Fulgent Genetics at Neutral
Street Insider News
over a year ago at www.macroaxis.com         
Sale by Jian Xie of 1779 shares of Fulgent Genetics
Macroaxis News
over a year ago at gurufocus.com         
Whats Driving Twist Bioscience Corps Surprising 14 percent Stock Rally?
Gurufocus Stories at Macroaxis
over a year ago at thelincolnianonline.com         
Covestor Ltd Acquires 834 Shares of Fulgent Genetics, Inc.
news
over a year ago at thelincolnianonline.com         
Fulgent Genetics, Inc. Position Increased by Mirae Asset Global Investments Co. Ltd.
news
over a year ago at news.google.com         
The 3 Best Digital Health Stocks for Personalized Medicine - Nasdaq
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Fulgent Genetics that are available to investors today. That information is available publicly through Fulgent media outlets and privately through word of mouth or via Fulgent internal channels. However, regardless of the origin, that massive amount of Fulgent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fulgent Genetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fulgent Genetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fulgent Genetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fulgent Genetics alpha.

Fulgent Genetics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Schrodinger Moves 14.1 percent Higher Will This Strength Last
01/23/2025
2
Disposition of 4733 shares by Jian Xie of Fulgent Genetics at 17.21 subject to Rule 16b-3
01/24/2025
3
Disposition of tradable shares by Gao Hanlin of Fulgent Genetics at 17.0 subject to Rule 16b-3
01/30/2025
4
Disposition of 1472 shares by Ming Hsieh of Fulgent Genetics at 16.64 subject to Rule 16b-3
01/31/2025
5
TruBridge Soars 6.4 percent Is Further Upside Left in the Stock
02/12/2025
6
Disposition of 733 shares by Paul Kim of Fulgent Genetics at 16.46 subject to Rule 16b-3
02/21/2025
7
Acquisition by Ming Hsieh of 11280 shares of Fulgent Genetics subject to Rule 16b-3
02/25/2025
8
Disposition of 11773 shares by Ming Hsieh of Fulgent Genetics at 16.24 subject to Rule 16b-3
02/26/2025
9
Disposition of 1914 shares by Paul Kim of Fulgent Genetics at 16.29 subject to Rule 16b-3
02/27/2025
10
Fulgent Genetics Inc Q4 2024 Earnings EPS Loss of Beats Estimate, Revenue at 76. ...
02/28/2025
11
Fulgent Sun International Is Due To Pay A Dividend Of NT2.00
03/04/2025
12
Insider Buying Paul Kim Acquires 100,000 Shares of Fulgent Genetics Inc
03/06/2025
13
Disposition of 4344 shares by Jian Xie of Fulgent Genetics at 20.1 subject to Rule 16b-3
03/07/2025

Additional Tools for Fulgent Stock Analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.